EP2848258
Meðhöndlun ættgengrar öldusóttar með and-IL-1betamótefnum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.10.2006EP published:
13.12.2017EP application number:
14191582.7
EP translation filed:
7.2.2018Grant published:
15.3.2018EPO information:
European Patent Register
Max expiry date:
23.10.2026Expiry date:
23.10.2026
Title:
Treatment of familial Mediterranean Fever with anti IL-1beta antibodies
Timeline
Today
24.10.2006EP application
13.12.2017EP Publication
7.2.2018Translation submitted
15.3.2018Registration published
23.10.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Lowe, PhilAddress:
Basel, CH
Name:
Gram, HermannAddress:
Weil, DE
Name:
Jung, ThomasAddress:
Zug, CH
Name:
Wright, TimothyAddress:
Swampscott, MA, US
Name:
Mundel, TrevorAddress:
Carlisle, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
730435 PDate:
26.10.2005Country:
US
Number:
742125 PDate:
2.12.2005Country:
US
Supplementary protection
SPC number:
SPC229
Classification
Categories:
A61K 39/395, A61P 37/00, A61P 19/02, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 24.9.2018
Expires: 23.10.2019
Payer: Árnason Faktor
Number: 14
Paid: 23.9.2019
Expires: 23.10.2020
Payer: Árnason Faktor
Number: 15
Paid: 24.9.2020
Expires: 23.10.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 27.9.2021
Expires: 23.10.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 27.9.2022
Expires: 23.10.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 11.10.2023
Expires: 23.10.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 23.9.2024
Expires: 23.10.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 22.10.2025
Expires: 23.10.2026
Payer: Árnason Faktor ehf.